HAUGHEY THOMAS 4
4 · ANI PHARMACEUTICALS INC · Filed Jun 10, 2026
Research Summary
AI-generated summary of this filing
ANIP Director Thomas Haughey Receives Award, Sells Shares
What Happened
Director Thomas Haughey received a restricted stock award of 4,357 shares on May 21, 2026 (acquisition reported at $0.00). He later sold 2,000 shares in an open-market transaction on June 8, 2026 at $80.88 per share, generating $161,760. The award is subject to vesting; the sale was executed under a pre-established 10b5-1 trading plan.
Key Details
- Award date: 2026-05-21 — 4,357 restricted shares granted (acquisition price $0.00). Footnote F1: vests in full on May 21, 2027.
- Sale date: 2026-06-08 — 2,000 shares sold at $80.88/share for $161,760. Footnote F2: sale effected pursuant to a Rule 10b5-1 plan adopted March 9, 2026.
- Filing: Form 4 filed June 10, 2026 (Accession: 0001272247-26-000004).
- Shares owned after transaction: not specified in the filing.
- Transaction types: A = Award/Grant; S = Open-market Sale. No tax-withholding or other dispositions reported.
Context
Restricted stock awards are compensation and typically vest over time; they do not necessarily signal a buy decision by the insider. The sale was pre-planned under a 10b5-1 trading arrangement, which is commonly used to execute trades according to a preset schedule and can reduce the appearance of trading on inside information. This Form 4 reports both a grant and a sale; retail investors should view the award as compensation-related and the sale as executed under a scheduled plan.
Insider Transaction Report
- Award
Common Stock
[F1]2026-05-21+4,357→ 40,878 total - Sale
Common Stock
[F2]2026-06-08$80.88/sh−2,000$161,760→ 38,878 total
Footnotes (2)
- [F1]Represents a restricted stock award that will vest in full on May 21, 2027.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2026.